National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 9247 [2014-03400]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 32 / Tuesday, February 18, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Environmental Health Sciences Council,
February 19, 2014, 08:30 a.m. to
February 20, 2014, 11:00 p.m., Nat. Inst.
of Environmental Health Sciences,
Building 101, Rodbell Auditorium, 111
T.W. Alexander Drive, Research
Triangle Park, NC 27709, which was
published in the Federal Register on
January 15, 2014, 79 FR 2678.
This Federal Register Notice is
amending the second day of this
meeting. February 20, 2014 will now
have an open session from 8:30 a.m. to
9:30 a.m. The closed session on
February 20, 2014 will now run from
9:35 a.m. to 11:30 a.m. The meeting is
partially Closed to the public.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health
Building 31, 3C02, 31 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Andrew J. Griffith, Ph.D.,
MD, Director, Division of Intramural
Research, National Institute on Deafness and
Other Communication Disorders, 35A
Convent Drive, GF 103 Rockville, MD 20892,
301–496–1960, griffita@nidcd.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/groups/bsc/,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health,
HHS).
Dated: February 11, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03409 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
Dated: February 11, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–03405 Filed 2–14–14; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDCD.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute on Deafness and
Other Communication Disorders,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDCD.
Date: March 21, 2014.
Time: 1:00 p.m. to 2:00 p.m.
VerDate Mar<15>2010
21:55 Feb 14, 2014
Jkt 232001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: March 11–13, 2014.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3259B, 6700B Rockledge Drive, Bethesda,
MD 20817, (Telephone Conference Call).
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 6700B Rockledge Drive, MSC–7616,
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
9247
Bethesda, MD 20892–7616, 301–496–3253,
nvazquez@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Planning Grant (R34) and Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: March 19, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3121, 6700B Rockledge Drive, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Paul A. Amstad,
Ph.D.,Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities,NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–402–7098, pamstad@
niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Resource-Related
Research Projects (R24).
Date: March 21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DHHS/NIH/NIAID/DEA, 6700B
Rockledge Drive, MSC–7616, Bethesda, MD
20892, 301–402–8399, rosenthalla@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03400 Filed 2–14–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Advisory Board, February 26, 2014,
06:00 p.m. to February 27, 2014, 05:00
p.m., National Institutes of Health,
Building 31, 31 Center Drive, Bethesda,
MD, 20892 which was published in the
Federal Register on February 3, 2014,
79 FR 6205.
The meeting notice is amended to
change the start and end time of the
Subcommittee meeting on Planning and
Budget, and to change the start time of
E:\FR\FM\18FEN1.SGM
18FEN1
]]>Agencies
[Federal Register Volume 79, Number 32 (Tuesday, February 18, 2014)]
[Notices]
[Page 9247]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03400]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: March 11-13, 2014.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3259B, 6700B
Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Nancy Vazquez-Maldonado, Ph.D., Scientific
Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-3253,
nvazquez@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, NIAID Clinical Trial Planning Grant
(R34) and Clinical Trial Implementation Cooperative Agreement (U01).
Date: March 19, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3121, 6700B Rockledge
Drive, Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Paul A. Amstad, Ph.D.,Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616,
301-402-7098, pamstad@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, NIAID Resource-Related Research
Projects (R24).
Date: March 21, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817, (Telephone Conference Call).
Contact Person: Louis A. Rosenthal, Ph.D., Scientific Review
Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, 6700B
Rockledge Drive, MSC-7616, Bethesda, MD 20892, 301-402-8399,
rosenthalla@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03400 Filed 2-14-14; 8:45 am]
BILLING CODE 4140-01-P
